| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.108 | 10.955 | 13.819 | 20.164 | 30.622 | 32.389 |
| Total Income - EUR | - | - | - | - | 12.188 | 33.775 | 14.772 | 20.718 | 31.174 | 35.612 |
| Total Expenses - EUR | - | - | - | - | 10.178 | 33.640 | 13.922 | 8.271 | 30.481 | 37.882 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.010 | 135 | 850 | 12.447 | 693 | -2.269 |
| Net Profit/Loss - EUR | - | - | - | - | 1.989 | 35 | 670 | 12.098 | 594 | -2.961 |
| Employees | - | - | - | - | 3 | 3 | 2 | 1 | 3 | 4 |
Check the financial reports for the company - Dimulescu Sevymed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 562 | 6.350 | 5.658 | 5.122 | 4.958 | 7.010 |
| Current Assets | - | - | - | - | 21.221 | 4.295 | 2.848 | 13.266 | 9.286 | 2.942 |
| Inventories | - | - | - | - | 0 | 410 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 122 | 2 | 6.085 | 26 | 1.836 |
| Cash | - | - | - | - | 21.221 | 3.763 | 2.846 | 7.181 | 9.260 | 1.106 |
| Shareholders Funds | - | - | - | - | 2.031 | 2.027 | 2.652 | 12.147 | 6.639 | 3.641 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.647 | 1.679 | 21 | 944 | 2.877 | 4.832 |
| Income in Advance | - | - | - | - | 18.106 | 6.939 | 5.832 | 5.297 | 4.729 | 1.479 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8891 - 8891" | |||||||||
| CAEN Financial Year |
8891
|
|||||||||
Comments - Dimulescu Sevymed S.r.l.